688117 Stock Overview
ChengDu ShengNuo Biotec Co.,Ltd. engages in the research and development, production, sale, and export of peptide drugs.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
ChengDu ShengNuo Biotec Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥28.54 |
| 52 Week High | CN¥35.38 |
| 52 Week Low | CN¥16.46 |
| Beta | 0.63 |
| 1 Month Change | -0.59% |
| 3 Month Change | 25.73% |
| 1 Year Change | 25.49% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -39.01% |
Recent News & Updates
Shareholder Returns
| 688117 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 8.8% | 4.9% | 2.1% |
| 1Y | 25.5% | -13.4% | -14.2% |
Return vs Industry: 688117 exceeded the CN Pharmaceuticals industry which returned -13.4% over the past year.
Return vs Market: 688117 exceeded the CN Market which returned -14.2% over the past year.
Price Volatility
| 688117 volatility | |
|---|---|
| 688117 Average Weekly Movement | 8.7% |
| Pharmaceuticals Industry Average Movement | 7.6% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 688117's share price has been volatile over the past 3 months.
Volatility Over Time: 688117's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 984 | Yongjun Wen | www.snbiopharm.com |
ChengDu ShengNuo Biotec Co.,Ltd. engages in the research and development, production, sale, and export of peptide drugs. The company produces polypeptide APIs, tablets of solid preparation, bottles of freeze-dried powder injections, small-volume injections, pre-filled injections, and card type injections.
ChengDu ShengNuo Biotec Co.,Ltd. Fundamentals Summary
| 688117 fundamental statistics | |
|---|---|
| Market cap | CN¥3.20b |
| Earnings (TTM) | CN¥72.78m |
| Revenue (TTM) | CN¥457.56m |
43.9x
P/E Ratio7.0x
P/S RatioIs 688117 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688117 income statement (TTM) | |
|---|---|
| Revenue | CN¥457.56m |
| Cost of Revenue | CN¥167.00m |
| Gross Profit | CN¥290.57m |
| Other Expenses | CN¥217.79m |
| Earnings | CN¥72.78m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.65 |
| Gross Margin | 63.50% |
| Net Profit Margin | 15.91% |
| Debt/Equity Ratio | 32.0% |
How did 688117 perform over the long term?
See historical performance and comparison